Posted on: November 13, 2021 Posted by: Seema Comments: 0

Bharat Biotech’s Covaxin will be added to the UK government’s list of approved COVID-19 vaccinations for international passengers on November 22. What it mean’s, those injected with the Bharat Biotech-produced vaccine will not need to self-isolate once they arrive in England.

The move follows the World Health Organization’s (WHO) Emergency Use Listing for Covaxin, India’s second most often used formulation.

Covishield, the Oxford-AstraZeneca COVID-19 vaccine made in India, was added to the UK’s authorized list last month. The changes will take effect on November 22 at 4 a.m.

The development, according to British High Commissioner to India Alex Ellis, is good news for Indian visitors to the UK.

All youngsters under the age of 18 will be treated as fully vaccinated at the border beginning November 22. They will not be required to be tested prior to departure, to self-isolate upon arrival, or to submit to a test on the eighth day of their arrival.

Covaxin, the second most often used formulation in India, has also been placed on the World Health Organization’s Emergency Use List (WHO).

Passengers who have received all of their vaccines will not be required to do a pre-departure test, a day-8 test, or a self-isolation test when they arrive.

In addition to Covaxin, the UK government will recognize Sinovac and Sinopharm, both of which are on the WHO Emergency Use List, as approved vaccinations for incoming travel, benefiting fully vaccinated travelers from Malaysia and the UAE.

Leave a Comment